Overview

APIDRA Registration Study

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

To collect effectiveness and safety data during the treatment with Apidra glulisine (HMR1964) by means of subcutaneous injections to patients with Diabetes Mellitus 1st type during 12 weeks-active phase.

Phase:

Phase 4

Details

Lead Sponsor:

Sanofi

Treatments:

Insulin glulisine